These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20440038)

  • 21. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients.
    Ruchin PE; Trabattoni D; Fabbiocchi F; Montorsi P; Lualdi A; Ravagnani P; Grancini L; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Int J Cardiol; 2009 May; 134(2):231-7. PubMed ID: 18582971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease.
    Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW
    Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left main coronary artery stenting: crossing the Rubicon.
    Alfonso F
    J Am Coll Cardiol; 2009 May; 53(19):1769-72. PubMed ID: 19422983
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on drug-eluting stents.
    Sims JM
    Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-stent technique: a dead duck or alive and kicking?
    Belardi JA
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous coronary intervention of bifurcation coronary disease.
    Suzuki N; Angiolillo DJ; Kawaguchi R; Futamatsu H; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Feb; 55(1):57-71. PubMed ID: 17287681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-PCI white blood cell count: should we care?
    Lao D; Yeghiazarians Y
    J Invasive Cardiol; 2009 May; 21(5):207-8. PubMed ID: 19411719
    [No Abstract]   [Full Text] [Related]  

  • 29. The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.
    Taggart D
    J Am Coll Cardiol; 2008 Nov; 52(20):1680-1; author reply 1681. PubMed ID: 18992662
    [No Abstract]   [Full Text] [Related]  

  • 30. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
    Vermeersch P; Agostoni P
    Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
    Baber U; Akhter M; Kothari S; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The drug-eluting stent saga.
    Windecker S; Jüni P
    Circulation; 2009 Feb; 119(5):653-6. PubMed ID: 19204314
    [No Abstract]   [Full Text] [Related]  

  • 35. Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients.
    Chiu M; Ko DT; Austin PC; Cohen EA; Velianou JL; Goeree R; Blackhouse G; Tu JV
    Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):96-107. PubMed ID: 20031821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
    King SB; Hannan EL
    Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 38. Treating coronary bifurcations: neither rhyme nor reason?
    El-Jack S
    J Interv Cardiol; 2009 Jun; 22(3):257-60. PubMed ID: 19638098
    [No Abstract]   [Full Text] [Related]  

  • 39. "Stick the landing," for optimal ostial placement of stents.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 May; 73(6):769-70. PubMed ID: 19367630
    [No Abstract]   [Full Text] [Related]  

  • 40. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.